The JSE was firmer on Wednesday in line with European markets as progress in finding a Covid-19 vaccine lifted investor sentiment. 

An experimental Covid-19 vaccine trial by US-based biotech company Moderna, which is in its early stages, showed immune response in all 45 patients, according to US researchers. 

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now